CAPPELLO, Paola
 Distribuzione geografica
Continente #
NA - Nord America 8.403
EU - Europa 5.278
AS - Asia 3.648
AF - Africa 139
OC - Oceania 92
SA - Sud America 58
Continente sconosciuto - Info sul continente non disponibili 10
Totale 17.628
Nazione #
US - Stati Uniti d'America 8.282
CN - Cina 2.240
IT - Italia 1.514
SE - Svezia 704
IE - Irlanda 514
DE - Germania 504
TW - Taiwan 345
FR - Francia 331
UA - Ucraina 328
AT - Austria 279
KR - Corea 242
GB - Regno Unito 231
FI - Finlandia 230
PL - Polonia 195
JP - Giappone 147
SG - Singapore 142
VN - Vietnam 142
DK - Danimarca 115
SN - Senegal 113
IN - India 103
CA - Canada 91
HK - Hong Kong 88
AU - Australia 86
TR - Turchia 86
BE - Belgio 57
NL - Olanda 49
CH - Svizzera 40
BR - Brasile 37
RU - Federazione Russa 37
ES - Italia 34
MX - Messico 25
IR - Iran 22
GR - Grecia 18
HU - Ungheria 12
RO - Romania 12
UZ - Uzbekistan 12
NO - Norvegia 11
CZ - Repubblica Ceca 10
EU - Europa 10
PT - Portogallo 10
TH - Thailandia 10
BY - Bielorussia 9
IL - Israele 9
ID - Indonesia 8
NG - Nigeria 8
EE - Estonia 7
LU - Lussemburgo 7
MO - Macao, regione amministrativa speciale della Cina 7
AR - Argentina 6
CL - Cile 6
EG - Egitto 6
LB - Libano 6
NZ - Nuova Zelanda 6
PK - Pakistan 6
IQ - Iraq 5
SA - Arabia Saudita 5
ZA - Sudafrica 5
AE - Emirati Arabi Uniti 4
MY - Malesia 4
PR - Porto Rico 4
AL - Albania 3
HR - Croazia 3
LK - Sri Lanka 3
PE - Perù 3
PH - Filippine 3
RS - Serbia 3
SC - Seychelles 3
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
CY - Cipro 2
DZ - Algeria 2
EC - Ecuador 2
MD - Moldavia 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
VE - Venezuela 2
BD - Bangladesh 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BT - Bhutan 1
BZ - Belize 1
CO - Colombia 1
GH - Ghana 1
IM - Isola di Man 1
JO - Giordania 1
NP - Nepal 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
YE - Yemen 1
Totale 17.628
Città #
Chandler 1.210
Beijing 722
Houston 576
Fairfield 533
Dublin 513
Ann Arbor 461
Ashburn 359
Torino 320
Woodbridge 299
Vienna 276
Wilmington 267
Nyköping 263
Taipei 261
Dearborn 246
Jacksonville 236
Redwood City 236
Seattle 202
Shanghai 185
Cambridge 178
Villeurbanne 165
Guangzhou 161
Medford 161
Warsaw 158
Princeton 153
Pisa 143
Turin 128
Los Angeles 114
Fremont 109
Dong Ket 96
Rome 84
Nanjing 83
Milan 71
Wuhan 67
Boston 66
Hangzhou 66
Boardman 60
Singapore 50
Washington 46
San Diego 45
Chengdu 44
Tokyo 42
Shenyang 41
Zhengzhou 39
Changsha 36
Brussels 34
New York 34
Changchun 32
Seoul 32
Xian 31
Norwalk 29
Verona 29
Kunming 27
Hebei 25
Munich 25
London 24
Helsinki 22
San Mateo 22
Toronto 22
Phoenix 21
Düsseldorf 19
Hefei 19
Jinan 19
Chongqing 18
Heidelberg 18
Melbourne 17
Nanchang 17
Detroit 16
Falls Church 16
Lanzhou 16
Polska 16
Seongnam 16
Fuzhou 15
Ottawa 15
Paris 15
Silver Spring 15
Tianjin 15
Chennai 14
Hong Kong 14
Istanbul 14
Villadose 14
Farmington 13
Mountain View 13
Upper Marlboro 13
Central 12
Piemonte 12
Pittsburgh 12
Rochester 12
Asti 11
Bethesda 11
Erlangen 11
Napoli 11
Oxford 11
Palermo 11
Philadelphia 11
San Jose 11
Florence 10
Genova 10
Odense 10
Redmond 10
Bari 9
Totale 10.542
Nome #
Alpha-Enolase (ENO1), a potential target in novel immunotherapies 1.510
Phosphoinositide 3-Kinase Gamma Inhibition Protects from Anthracycline Cardiotoxicity and Reduces Tumor Growth 489
Class II Transactivator-Induced MHC Class II Expression in Pancreatic Cancer Cells Leads to Tumor Rejection and a Specific Antitumor Memory Response. 428
Circulating Autoantibodies to Phosphorylated α-Enolase are a Hallmark of Pancreatic Cancer. 413
Vaccination with ENO1 DNA Prolongs Survival of Genetically Engineered Mice with Pancreatic Cancer. 404
A bioluminescent mouse model of proliferation to highlight early stages of pancreatic cancer: A suitable tool for preclinical studies 394
Role of Nek2 on centrosome duplication and aneuploidy in breast cancer cells 392
Molecular and genetic bases of pancreatic cancer 367
Regulation of Langerhans cell functions in a hypoxic environment 310
Hypoxia modulates the gene expression profile of immunoregulatory receptors in human mDCs: identification of TREM-1 as a novel hypoxic marker in vitro and in vivo. 284
The advanced glycation end-product Nϵ-carboxymethyllysine promotes progression of pancreatic cancer: implications for diabetes-associated risk and its prevention 282
Alpha-enolase (ENO1) controls alpha v/beta 3 integrin expression and regulates pancreatic cancer adhesion, invasion, and metastasis 263
CC-chemokine ligand 16 induces a novel maturation program in human immature monocyte-derived dendritic cells 236
The interferon-inducible IFI16 gene inhibits tube morphogenesis and proliferation of primary, but not HPV16 E6/E7-immortalized human endothelial cells 231
The proapoptotic activity of the Interferon-inducible gene IFI16 provides new insights into its etiopathogenetic role in autoimmunity. 228
CCL16 activates an angiogenic program in vascular endothelial cells 227
Targeting the Warburg effect in cancer cells through ENO1 knockdown rescues oxidative phosphorylation and induces growth arrest 215
Pancreatic cancer vaccine: a unique potential therapy 214
FAM49B, a novel regulator of mitochondrial function and integrity that suppresses tumor metastasis 203
Targeting of surface alpha-enolase inhibits the invasiveness of pancreatic cancer cells 202
Anti-α-enolase antibody limits the invasion of myeloid-derived suppressor cells and attenuates their restraining effector T cell response 196
Macrophage PI3Kγ drives pancreatic ductal adenocarcinoma progression 191
Peripheral ENO1-specific T cells mirror the intratumoral immune response and their presence is a potential prognostic factor for pancreatic adenocarcinoma 189
α-enolase: a promising therapeutic and diagnostic tumor target 187
Depletion of tumor-associated macrophages switches the epigenetic profile of pancreatic cancer infiltrating T cells and restores their anti-tumor phenotype 181
Autoantibodies to Ezrin are an early sign of pancreatic cancer in humans and in genetically engineered mouse models. 172
The interferon-inducible gene IFI16 secretome of endothelial cells drives the early steps of the inflammatory response 168
Chimeric Rat/Human HER2 Efficiently Circumvents HER2 Tolerance in Cancer Patients. 167
Next generation immunotherapy for pancreatic cancer: DNA vaccination is seeking new combo partners 165
IL-1β+ macrophages fuel pathogenic inflammation in pancreatic cancer 153
Stromal protein βig-h3 reprogrammes tumour microenvironment in pancreatic cancer 151
Reactive oxygen species modulate macrophage immunosuppressive phenotype through the up-regulation of PD-L1 150
Spatial distribution of B cells predicts prognosis in human pancreatic adenocarcinoma 139
In pancreatic cancer chemotherapy increases anti-tumor responses to tumor associated antigens and potentiates DNA vaccination 139
AhR controls redox homeostasis and shapes the tumor microenvironment in BRCA1-associated breast cancer 138
Three are better than one: plasminogen receptors as cancer theranostic targets. 138
Humoral immune responses toward tumor-derived antigens in previously untreated patients with chronic lymphocytic leukemia 132
The hypoxic environment induces a migratory or a proinflammatory phenotype in DCs depending on their maturation stage. Identification of TREM-1 as a common hypoxia marker 132
BLOCKADE OF SURFACE ALPHA-ENOLASE (ENO1) AS A NOVEL IMMUNOTHERAPEUTIC APPROACH IN PANCREATIC CANCER 130
Antibody and T cell response profiling of pancreatic cancer patients before and after chemotherapy reveals increased recognition of antigens suitable for immunotherapy 130
Early expression of the fractalkine receptor CX3CR1 in pancreatic carcinogenesis. 129
Strigolactones as antiviral drugs to inhibit Herpesvirus replication 127
An integrated humoral and cellular response is elicited in pancreatic cancer by alpha-enolase, a novel pancreatic ductal adenocarcinoma associated antigen 126
Antibody and T cell response profiling in pancreatic cancer patients before and after chemotherapy identify tumor associated antigens suitable for immunotherapy 124
Strigolactone analogs are promising antiviral agents against Herpesviruses 121
Activation of T cells against HER-2/neu+ by autologous dendritic cells loaded with rat HER-2/neu+ cells in the presence of CCL16 119
Identification of Novel Tumor-Associated Antigens in Chronic Lymphocytic Leukemia (CLL) by Serological Proteome Analysis (SERPA) 119
Endogenous glutamine decrease is associated with pancreatic cancer progression 113
Autoantibody signature in human ductal pancreatic adenocarcinoma 108
Tumor rejection and immune memory elicited by locally released LEC chemokine are associated with an impressive recruitment of APCs, lymphocytes, and granulocytes. 106
Next generation of cancer immunotherapy calls for combination 105
Activation of T cells against human HER-2/neu by autologous Dendritic Cells loaded with rat HER-2/neu+ cells in the presence of CCL16 104
A Mouse To Human Autoantibody Signature in Pancreatic Ductal Adenocarcinoma 103
DNA vaccination with alpha-enolase effectively prolongs survival in amouse model of human pancreatic cancer. 103
Neuromuscular blocking agent cisatracurium attenuates lung injury by inhibition of nicotinic acetylcholine Receptor-α1 98
Alpha-enolase elicits specific adenocarcinoma pancreatic-T cell responses in healthy donors and tumor patients 96
Human dendritic cells differentiated in hypoxia down modulate antigen uptake and change their chemokine expression profile 96
Identification of tumor associated antigens in pancreatic cancer by serological proteome analysis 96
CCL16, a powerful tool for monocyte-derived dendritic cell maturation 96
Gut microbiota composition after diet and probiotics in overweight breast cancer survivors: a randomized open-label pilot intervention trial 95
The balance between IL-17 and IL-22 produced by liver-infiltrating T-helper cells critically controls NASH development in mice 91
AN ISOLATED MONOPHOSPHORYLATED PEPTIDE DERIVED FROM HUMAN ALPHA-ENOLASE USEFUL FOR DIAGNOSIS AND TREATMENT OF PANCREATIC ADENOCARCINOMA, ANTIBODIES DIRECTED AGAINST THE SAID MONOPHOSPHORYLATED PEPTIDE, AND USES THEREOF 89
Serological Proteome Analysis (SERPA) as a tool for the identification of novel tumor antigens in chronic lymphocytic leukemia (CLL) 89
Abstract 4984: Chemotherapy induces a coordinate autoantibody and T-cell response against tumor-associated antigens in pancreatic cancer patients 88
Peptide monofosforilato isolato derivato dall'alfaenolasi umana utile per la diagnosi e il trattamento dell'adenocarcinoma pancreatico, anticorpi diretti contro il suddetto peptide monofosforilato e loro usi 87
G PROTEIN COUPLED RECEPTORS MEDIATE FIBROBLAST CHEMOTAXIS INDUCED BY BRONCOALVEOLAR LAVAGE FLUID OF ARDS PATIENTS 87
The dark side of immunotherapy: pancreatic cancer 87
Identification of chemotherapy-induced antigens suitable for immunotherapy in pancreatic cancer patients 87
Autoantibodies to the ectoenzyme a enolase, identify a pancreatic adenocarcinoma (PDA)-associated antigen that elicits both CD4 and CD8 T cell response 85
THE BLOCKADE OF PLASMINOGEN-ALPHA-ENOLASE INTERACTION INHIBITS THE INVASION OF PANCREATIC CANCER CELLS. 85
Identification of tumor associated antigens in pancreatic cancer by serological proteome analysis 84
Abstract B49: Alpha-enolase knockdown reprograms metabolism and points out targetable pathways to counteract PDA growth 84
The Glycolytic Pathway as a Target for Novel Onco-Immunology Therapies in Pancreatic Cancer 84
Role of dendritic cell-derived CXCL13 in the pathogenesis of Bartonella henselae B-rich granuloma 82
Strigolactone Analogs Are Promising Antiviral Agents for the Treatment of Human Cytomegalovirus Infection. 82
Vaccino a DNA per l’uso nel trattamento profilattico o terapeutico dell’adenocarcinoma duttale pancreatico 82
Transcriptome of hypoxic immature dendritic cells: modulation of chemokine/receptor expression. 81
Identification by serological proteome analysis (SERPA) of novel tumor associated antigens in chronic lymphocytic leukemia (CLL) 81
Identification by serological proteome analysis (SERPA) of tumor-associated antigens eliciting antibody-responses in chronic lymphocytic leukemia 79
SEROLOGICAL PROTEOME ANALYSIS (SERPA) FOR THE IDENTIFICATION OF TUMOR-ASSOCIATED ANTIGENS ELICITING ANTIBODY-RESPONSES IN CHRONIC LYMPHOCYTIC LEUKEMIA 79
Molecola perturbation of IFNγR2 internalization reinstates T cell sensitività to the IFNγ/STAT1 signaling pathway in vitro and in vivo. 5th 78
Expression of IFNgammaR2 mutated in a dileucine internalization motif reinstates IFNgamma signaling and apoptosis in human T lymphocytes 78
Ventilatory Management During Normothermic Ex Vivo Lung Perfusion: Effects on Clinical Outcomes 78
Human dendritic cells differentiated in hypoxia down-modulate antigen uptake and change their chemokine/receptor expression profile 77
IL17A Depletion Affects the Metabolism of Macrophages Treated with Gemcitabine 77
Apoptosis in the development of the mouse olfactory epithelium. 77
The ectoenzyme α-enolase, a pancreatic adenocarcinoma (PDAC)-associated antigen, elicits both in vitro and in vivo T cell responses 76
Chronic hypoxia reprograms human immature dendritic cells by inducing a proinflammatory phenotype and TREM-1 expression. 76
Soluble stroma-related biomarkers of pancreatic cancer 76
Hypoxia inhibits antigen up-take by immature human dendritic cells 75
IL17A CRITICALLY SHAPES THE TRANSCRIPTIONAL PROGRAM OF FIBROBLASTS IN PANCREATIC CANCER AND SWITCHES ON THEIR PRO-TUMORIGENIC FUNCTIONS 75
CCL16 chemokine optimizes tumor antigen presentation by inducing a new human dendritic cell maturation stage. “9th 74
The interferon-inducible gene IFI16, a member of the HIN200 family, triggers primary endothelial cell apoptosis through caspase 2 and caspase 3 pathway 73
Chronic hypoxia reprograms human immature dendritic cells by inducing a proinflammatory phenotype and TREM-1 expression 73
Survival and Migration of Human Dendritic Cells AreRegulated by an IFN-alpha-Inducible Axl/Gas6 Pathway 71
α-enolase ectoenzyme, a pancreatic adenocarcinoma (PDAC)-associated antigen, elicits both in vitro and in vivo T cell responses 70
LAG-3 enables DNA vaccination to persistently prevent mammary carcinogenesis in HER-2/neu transgenic BALB/c mice. 68
Identification of tumor associated antigens in pancreatic cancer by serological proteome analysis (SERPA) 68
Discovery of Targets for Cancer Immunoprevention 68
L’ectoenzima a-aenolasi, un antigene associato al carcinoma pancreatico identificato mediante serological protome analysis (SERPA), induce una risposta specifica in linfociti CD4+ e CD8+ 67
Totale 15.792
Categoria #
all - tutte 41.899
article - articoli 0
book - libri 0
conference - conferenze 10.055
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.954


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019593 0 0 0 0 0 0 0 0 0 0 397 196
2019/20203.227 165 174 236 352 224 575 307 222 320 253 215 184
2020/20212.637 196 154 203 149 288 254 210 160 273 218 190 342
2021/20222.633 157 160 165 261 168 149 215 158 79 190 498 433
2022/20233.466 268 295 80 403 328 776 227 310 389 123 137 130
2023/20241.724 214 246 140 102 196 222 101 119 26 125 233 0
Totale 18.218